Literature DB >> 26327768

Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.

Wei-Dong Li1, Kun-Fa Fu1, Gui-Mei Li1, Yan-Shu Lian1, Ai-Min Ren1, Yun-Jue Chen1, Jin-Rong Xia1.   

Abstract

AIM: To compare and analyze the effects of obesity and non-alcoholic fatty liver disease (NAFLD) on the incidence of type 2 diabetes mellitus (T2DM) in Chinese subjects.
METHODS: In 2008, a population of 4847 subjects was randomly sampled from 17 medical units for enrollment in this cohort study. Baseline information was obtained via a questionnaire on general information, physical examination (height, weight, and blood pressure), laboratory tests (triglycerides, total cholesterol, fasting blood glucose, alanine aminotransferase (ALT), uric acid, and creatinine), B-mode ultrasound, and ECG screening. The incidence of T2DM after four years of follow-up was calculated. Numeric variable data was tested for normality, with the data expressed as mean ± SD. Kaplan-Meier analysis was performed to calculate the cumulative incidence. The Cox proportional hazards model was used to analyze the relative risk (RR) of different body mass index (BMI) levels and NAFLD on T2DM, as well as analyzing the RR adjusted for age, sex, blood pressure, lipids, transaminases, uric acid, and creatinine.
RESULTS: A total of 4736 (97.71%) subjects completed 4-year follow-up, with a median follow-up time of 3.85 years, totaling 17223 person-years. 380 subjects were diagnosed with T2DM, with a cumulative incidence of 8.0%. The cumulative incidence of T2DM in the NAFLD and control groups was 17.4% vs 4.1% (P < 0.001), respectively, while the incidence in overweight and obese subjects was 11.0% vs 15.8% (P < 0.001), respectively. The incidence of T2DM increased with an increase in baseline BMI. Cox regression analysis showed that the risk of T2DM in the NAFLD group (RR = 4.492, 95%CI: 3.640-5.542) after adjustment for age, sex, blood pressure, lipids, ALT, uric acid, and creatinine was 3.367 (2.367-4.266), while the value (RR, 95%CI) in overweight and obese subjects after adjustment for age, sex, BMI, blood pressure, lipids and other factors was 1.274 (0.997-1.629) and 1.554 (1.140-2.091), respectively. Stratification of three BMI levels (BMI < 24 kg/m(2), 24 kg/m(2) ≤ BMI < 28 kg/m(2), BMI ≥ 28 kg/m(2)) showed that the risk of T2DM in the NAFLD group was significantly higher than that in the control group (RR = 3.860, 4.049 and 3.823, respectively).
CONCLUSION: Compared with BMI, NAFLD could be better at forecasting the risk of T2DM in Chinese subjects, and may be a high risk factor for T2DM, independent of overweight/obesity.

Entities:  

Keywords:  Cohort study; Incidence; Non-alcoholic fatty liver disease; Type 2 diabetes

Mesh:

Year:  2015        PMID: 26327768      PMCID: PMC4548121          DOI: 10.3748/wjg.v21.i32.9607

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  The guidelines for prevention and control of overweight and obesity in Chinese adults.

Authors:  Chunming Chen; Frank C Lu
Journal:  Biomed Environ Sci       Date:  2004       Impact factor: 3.118

2.  Racial disparities in the risk of developing obesity-related diseases: a cross-sectional study.

Authors:  Hong Zhang; Rosa Rodriguez-Monguio
Journal:  Ethn Dis       Date:  2012       Impact factor: 1.847

3.  Overweight in early adulthood, adult weight change, and risk of type 2 diabetes, cardiovascular diseases, and certain cancers in men: a cohort study.

Authors:  Renée de Mutsert; Qi Sun; Walter C Willett; Frank B Hu; Rob M van Dam
Journal:  Am J Epidemiol       Date:  2014-04-30       Impact factor: 4.897

Review 4.  A fresh look at NASH pathogenesis. Part 1: the metabolic movers.

Authors:  Claire Z Larter; Shiv Chitturi; Déborah Heydet; Geoffrey C Farrell
Journal:  J Gastroenterol Hepatol       Date:  2010-04       Impact factor: 4.029

5.  Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus.

Authors:  Anuradhani Kasturiratne; Sanjaya Weerasinghe; Anuradha S Dassanayake; Shaman Rajindrajith; Arjuna P de Silva; Norihiro Kato; A Rajitha Wickremasinghe; H Janaka de Silva
Journal:  J Gastroenterol Hepatol       Date:  2013-01       Impact factor: 4.029

Review 6.  The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes.

Authors:  Rachel J Perry; Varman T Samuel; Kitt F Petersen; Gerald I Shulman
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

7.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

Authors:  J Ludwig; T R Viggiano; D B McGill; B J Oh
Journal:  Mayo Clin Proc       Date:  1980-07       Impact factor: 7.616

8.  Effect of nonalcoholic Fatty liver disease on the development of type 2 diabetes in nonobese, nondiabetic korean men.

Authors:  Chang Wook Chon; Bum Soo Kim; Yong Kyun Cho; Ki Chul Sung; Ji Cheol Bae; Tae Wan Kim; Hyun Sun Won; Kwan Joong Joo
Journal:  Gut Liver       Date:  2012-07-12       Impact factor: 4.519

9.  Prevalence and Trends of Adult Obesity in the US, 1999-2012.

Authors:  Ruopeng An
Journal:  ISRN Obes       Date:  2014-01-06

10.  Chronic disease burden associated with overweight and obesity in Ireland: the effects of a small BMI reduction at population level.

Authors:  Karen Kearns; Anne Dee; Anthony P Fitzgerald; Edel Doherty; Ivan J Perry
Journal:  BMC Public Health       Date:  2014-02-10       Impact factor: 3.295

View more
  13 in total

1.  Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity.

Authors:  P Di Bonito; L Pacifico; C Chiesa; G Valerio; E Miraglia Del Giudice; C Maffeis; A Morandi; C Invitti; M R Licenziati; S Loche; G Tornese; F Franco; M Manco; M G Baroni
Journal:  J Endocrinol Invest       Date:  2016-11-16       Impact factor: 4.256

Review 2.  Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease.

Authors:  Frank T Spradley; Jillian A Smith; Barbara T Alexander; Christopher D Anderson
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-03-06       Impact factor: 4.310

Review 3.  Association of weight status and the risks of diabetes in adults: a systematic review and meta-analysis of prospective cohort studies.

Authors:  Hong-Jie Yu; Mandy Ho; Xiangxiang Liu; Jundi Yang; Pui Hing Chau; Daniel Yee Tak Fong
Journal:  Int J Obes (Lond)       Date:  2022-02-23       Impact factor: 5.551

4.  Associations of General and Central Adiposity With Incident Diabetes in Chinese Men and Women.

Authors:  Fiona Bragg; Kun Tang; Yu Guo; Andri Iona; Huaidong Du; Michael V Holmes; Zheng Bian; Christiana Kartsonaki; Yiping Chen; Ling Yang; Qiang Sun; Caixia Dong; Junshi Chen; Rory Collins; Richard Peto; Liming Li; Zhengming Chen
Journal:  Diabetes Care       Date:  2018-01-03       Impact factor: 19.112

5.  Early Clinical Expressions of Insulin Resistance: The Real Enemy to Look For.

Authors:  René Rodríguez-Gutiérrez; Alejandro Salcido-Montenegro; José Gerardo González-González
Journal:  Diabetes Ther       Date:  2017-12-05       Impact factor: 2.945

6.  Liver Fat, Hepatic Enzymes, Alkaline Phosphatase and the Risk of Incident Type 2 Diabetes: A Prospective Study of 132,377 Adults.

Authors:  Sean Chun-Chang Chen; Shan Pou Tsai; Jing-Yun Jhao; Wun-Kai Jiang; Chwen Keng Tsao; Ly-Yun Chang
Journal:  Sci Rep       Date:  2017-07-05       Impact factor: 4.379

7.  The Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population.

Authors:  Behnam Rabiee; Farzin Roozafzai; Gholam Reza Hemasi; Hossein Poustchi; Hossein Keyvani; Mahmood Reza Khonsari; Hossein Ajdarkosh; Mansooreh Maadi; Fatemeh Sima Saeedian; Farhad Zamani
Journal:  Middle East J Dig Dis       Date:  2017-04

8.  Ergosterol Alleviates Kidney Injury in Streptozotocin-Induced Diabetic Mice.

Authors:  Li Ang; Liu Yuguang; Wang Liying; Zhang Shuying; Xu Liting; Wang Shumin
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-17       Impact factor: 2.629

9.  Evaluation of serum lipid profile, body mass index, and waistline in Chinese patients with type 2 diabetes mellitus.

Authors:  Rongtao Cui; Zhiming Qi; Lin Zhou; Zuohong Li; Qing Li; Junyong Zhang
Journal:  Clin Interv Aging       Date:  2016-04-18       Impact factor: 4.458

10.  Relationship between 25-Hydroxyvitamin D Levels and Liver Fibrosis as Assessed by Transient Elastography in Patients with Chronic Liver Disease.

Authors:  Bong Jin Ko; Young Seok Kim; Sang Gyune Kim; Jung Hwan Park; Sae Hwan Lee; Soung Won Jeong; Jae Young Jang; Hong Soo Kim; Boo Sung Kim; Sun Mi Kim; Young Don Kim; Gab Jin Cheon; Bo Ra Lee
Journal:  Gut Liver       Date:  2016-09-15       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.